Body Interact was featured during the European Society of Cardiology conference, in Rome.
It supported highly interactive clinical case discussions with large audiences in two scientific sessions: “Oral anticoagulation + specific reversal = more control” and “NOACS are not all the same: new factors to consider in 2016”.
These events were sponsored by Boehringer Ingelheim.
